The anticancer drug ellipticine is an inducer of rat NAD(P)H : Quinone oxidoreductase

Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11310%2F07%3A11211" target="_blank" >RIV/00216208:11310/07:11211 - isvavai.cz</a>
Result on the web
—
DOI - Digital Object Identifier
—

Result language
angličtina
Original language name
The anticancer drug ellipticine is an inducer of rat NAD(P)H : Quinone oxidoreductase
Original language description
The antineoplastic agent ellipticine was investigated for its ability to induce the biotransformation enzyme NAD(P) H:quinone oxidoreductase (DT-diaphorase, EC 1.6.99.2) in male Wistar rats
Czech name
Protirakovinné léčivo ellipticin je induktor potkaní NAD(P)H : chinon oxidoreduktasy
Czech description
Byla studována schopnost antineoplastického agens ellipticin indukovat biotransformační enzym NAD(P) H:chinon oxidoreduktasu (DT-diaphorasa, EC 1.6.99.2) u potkanů Wistar

Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
CE - Biochemistry
OECD FORD branch
—

Project
Result was created during the realization of more than one project. More information in the Projects tab.
Continuities
P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)<br>Z - Vyzkumny zamer (s odkazem do CEZ)

Publication year
2007
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Result description